Hepatitis C virus core protein promotes immortalization of primary human hepatocytes

Virology

Volumn 271, Issue 1, 2000, Pages 197-204

  Ray, Ratna B ^a   Meyer, Keith ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CORE PROTEIN; TELOMERASE;

ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL STRUCTURE; ENZYME ACTIVITY; GROWTH REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRUS CORE;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0034713462     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0295     Document Type: Article

References (53)

1. Alter M. J. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15:1996;5-14.
2. Bishop J. M. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
3. Block G. D., Locker J., Bowen W. C., Petersen B. E., Katyal S., Strom S. C., Riley T., Howard T. A., Michalopoulos G. K. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGFα in a chemically defined (HGM) medium. J. Cell Biol. 132:1996;1133-1149.
4. Brash D. E., Reddel R. R., Quanrud M., Yang K., Farrell M. P., Harris C. C. Strontium phosphate transfection of human cells in primary culture: Stable expression of the simian virus 40 large-T-antigen gene in primary human bronchial epithelial cells. Mol. Cell. Biol. 7:1987;2031-2034.
5. Brown K. E., Paulos J. E., Li L., Soweid A. M., Ramm G. A., O'Neil R., Britton R. S., Bacon R. B. Effect of vitamin E supplementation on the hepatic fibrogenesis in chronic dietary iron overload. Am. J. Physiol. 272:1997;G116-123.
6. Bruchell A., Hume R., Burchell B. A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system. Clin. Chem. Acta. 173:1988;183-192.
7. Bryan T. M., Englezou A., Gupta J., Bacchetti S., Reddel R. R. Telomerase elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
8. Bukh J., Purcell R. H., Miller R. H. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA. 91:1994;8239-8243.
9. Chang J., Yang S. E., Cho Y.-G., Hwang S. B., Hahn Y. S., Sung Y. C. Hepatitis C virus from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72:1998;3060-3065.
10. Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Grieder C. W., Harley C. B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
11. Derman E., Krauter K., Walling L., Weinberger C., Ray M., Darnell J. E. Transcriptional control in the production of liver-specific mRNAs. Cell. 23:1991;731-739.
12. Fujie H., Yotsuyanagi H., Moriya K., Shintani Y., Tsutsumi T., Takayama T., Makuuchi M., Matsuura Y., Miyamura T., Kimura S., Koike K. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol. 59:1999;141-145.
13. Gale M. Jr., Kwieciszewski B., Dossett M., Nakao H., Katze M. G. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:1999;6506-6516.
14. Ghosh A. K., Steele R., Meyer K., Ray R., Ray R. B. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J. Gen. Virol. 80:1999;1179-1183.
15. Greenberg R. A., O'Hagan R. C., Deng H., Xiao Q., Hann S. R., Adams R. A., Lichtsteiner S., Chin L., Morin G. B., Depinho R. A. Telomerase reverse transcriptase gene is a direct target of c-myc but is not functionally equivalent in cellular transformation. Oncogene. 18:1999;1219-1226.
16. Greider C. W., Blackburn E. H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell. 43:1985;405-413.
17. Hamburger A. W., Salmon S. E. Development of a bioassay for human myeloma colony-forming cells. Prog. Clin. Biol. Res. 48:1980;23-41.
18. Harley C. B. Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res. 256:1991;271-282.
19. Hsieh T. Y., Matsumoto M., Chou H. C., Schneider R., Hwang S. B., Lee A. S., Lai M. M. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J. Biol. Chem. 273:1998;17651-17659.
20. Idilman R., DeMaria N., Colantoni A., VanThiel D. H. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral Hepatitis. 5:1998;285-299.
21. Isom H. C., Strom S. C. Sirica A. E. The Role of Cell Types in Hepatocarcinogenesis. 1992;266-298 CRC Press, Boca Raton.
22. Kim D. W., Suzuki R., Harada T., Saito I., Miyamura T. Trans-suppression of gene expression by hepatitis C virus core protein. Jpn. J. Med. Sci. Biol. 47:1994;211-220.
23. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
24. Linder S., Marshall H. Immortalization of primary cells by DNA tumor viruses. Exp. Cell Res. 191:1990;1-7.
25. Lo S. Y., Masiarz F., Hwang S. B., Lai M. M. C., Ou J. H. Differential subcellular localization of hepatitis C virus core gene products. Virology. 213:1995;455-461.
26. Lu W., Lo S., Chen M., Wu K., Fung Y. K. T., Ou J. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology. 264:1999;134-141.
27. Mamiya N., Worman H. J. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274:1999;15751-15756.
28. Matsumoto M., Hsieh T. Y., Zhu N., VanArsdale T., Hwang S. B., Jeng K. S., Gorbalenya A. E., Lo S. Y., Ou J. H., Ware C. F., Lai M. M. C. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J. Virol. 71:1997;1301-1309.
29. Moradpour D., Englert C., Wakita T., Wands J. R. Characterization of cell lines allowing tight expression of hepatitis C virus core protein. Virology. 222:1996;51-63.
30. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78:1997;1527-1531.
31. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1998;1065-1067.
32. Owsianka A. M., Patel A. H. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology. 257:1999;330-340.
33. Pfeifer A. M. A., Cole K. E., Smoot D. T., Weston A., Groopman J. D., Shields P. G., Vignaud J.-M., Juillerat M., Lipsky M. M., Trump B. F., Lechner J. F., Harris C. C. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acd. Sci. USA. 90:1993;5123-5127.
34. Ray R. B., Lagging L. M., Meyer K., Steele R., Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:1995;209-220.
35. Ray R. B., Meyer K., Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 226:1996a;176-182.
36. Ray R. B., Lagging L. M., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:1996b;4438-4443.
37. Ray R. B., Steele R., Meyer K., Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:1997;10983-10986.
38. WAF1/Cip1/Sid1 promoter activity. Gene. 208:1998;331-336.
39. Ruster B., Zeuzem S., Roth W. K. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 219:1996;911-915.
40. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
41. Sakamuro D., Furukawa T., Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH3T3 cells. J. Virol. 69:1995;3893-3896.
42. Saxena R., Ye M. Q., Ye, Emre S., Klion F., Nalesnik M. A., Thung S. N. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitic C cirrhosis. Liver Transplant. Surg. 5:1999;81-82.
43. Sedivy J. M. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc. Natl. Acad. Sci. USA. 95:1998;9078-9081.
44. Shih C. M., Lo S. J., Miyamura T., Chen S. Y., Lee Y. W. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:1993;5823-5832.
45. Shih C. M., Chen C. M., Chen S. Y., Lee Y. H. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69:1995;1160-1171.
46. Shimizu I., Yao D.-F., Horie C., Yasuda M., Shiba M., Hirie T., Nishikado T., Meng X.-Y., Ito S. Mutations in the hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China. J. Gastroenterol. 32:1997;47-55.
47. Shrivastava A., Manna S. K., Ray R., Aggarwal B. B. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72:1998;9722-9728.
48. Tsuchihara K., Hijikata M., Fukuda K., Kuroki T., Yamamoto N., Shimotohno K. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology. 258:1999;100-107.
49. Woodworth C. D., Krieder J. W., Mengel L., Miller T., Meng Y. L., Isom H. C. Tumorigenicity of simian virus 40-hepatocyte cell lines: Effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes. Mol. Cell. Biol. 8:1988;4492-4501.
50. Wu J. C., Merlino G., Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from transgenic for transforming growth factor α Proc. Natl. Acad. Sci. USA. 91:1994;674-678.
51. Yasui L.-R., Wakita T., Kohara K. T., Funahashi S. I., Ichikawa M., Kajita T., Moradpour D., Wands J. R., Kohara M. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72:1998;6048-6055.
52. Yeh C.-T., Lu S.-C., Chu C.-M., Liaw Y.-F. Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J. Gen. Virol. 78:1997;2761-2770.
53. You L. R., Chen C. M., Yeh T. S., Tsai T. Y., Mai R. T., Lin C. H., Lee Y. H. Hepatitis C virus core protein interacts with putative cellular putative RNA helicase. J. Virol. 73:1999;2841-2853.